Copyright Reports & Markets. All rights reserved.

Global Eosinophilic Asthma Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Eosinophilic Asthma Treatment by Type
    • 1.3.1 Overview: Global Eosinophilic Asthma Treatment Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Eosinophilic Asthma Treatment Consumption Value Market Share by Type in 2023
    • 1.3.3 Intravenous Infusion
    • 1.3.4 Subcutaneous Injection
  • 1.4 Global Eosinophilic Asthma Treatment Market by Application
    • 1.4.1 Overview: Global Eosinophilic Asthma Treatment Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Children
    • 1.4.3 Adults
    • 1.4.4 Teenagers
  • 1.5 Global Eosinophilic Asthma Treatment Market Size & Forecast
  • 1.6 Global Eosinophilic Asthma Treatment Market Size and Forecast by Region
    • 1.6.1 Global Eosinophilic Asthma Treatment Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Eosinophilic Asthma Treatment Market Size by Region, (2019-2030)
    • 1.6.3 North America Eosinophilic Asthma Treatment Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Eosinophilic Asthma Treatment Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Eosinophilic Asthma Treatment Market Size and Prospect (2019-2030)
    • 1.6.6 South America Eosinophilic Asthma Treatment Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East & Africa Eosinophilic Asthma Treatment Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 AstraZeneca
    • 2.1.1 AstraZeneca Details
    • 2.1.2 AstraZeneca Major Business
    • 2.1.3 AstraZeneca Eosinophilic Asthma Treatment Product and Solutions
    • 2.1.4 AstraZeneca Eosinophilic Asthma Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 AstraZeneca Recent Developments and Future Plans
  • 2.2 GSK
    • 2.2.1 GSK Details
    • 2.2.2 GSK Major Business
    • 2.2.3 GSK Eosinophilic Asthma Treatment Product and Solutions
    • 2.2.4 GSK Eosinophilic Asthma Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 GSK Recent Developments and Future Plans
  • 2.3 Genentech (Roche Group) & Novartis
    • 2.3.1 Genentech (Roche Group) & Novartis Details
    • 2.3.2 Genentech (Roche Group) & Novartis Major Business
    • 2.3.3 Genentech (Roche Group) & Novartis Eosinophilic Asthma Treatment Product and Solutions
    • 2.3.4 Genentech (Roche Group) & Novartis Eosinophilic Asthma Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Genentech (Roche Group) & Novartis Recent Developments and Future Plans
  • 2.4 Regeneron Pharmaceuticals & Sanofi
    • 2.4.1 Regeneron Pharmaceuticals & Sanofi Details
    • 2.4.2 Regeneron Pharmaceuticals & Sanofi Major Business
    • 2.4.3 Regeneron Pharmaceuticals & Sanofi Eosinophilic Asthma Treatment Product and Solutions
    • 2.4.4 Regeneron Pharmaceuticals & Sanofi Eosinophilic Asthma Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Regeneron Pharmaceuticals & Sanofi Recent Developments and Future Plans
  • 2.5 Teva Pharmaceuticals
    • 2.5.1 Teva Pharmaceuticals Details
    • 2.5.2 Teva Pharmaceuticals Major Business
    • 2.5.3 Teva Pharmaceuticals Eosinophilic Asthma Treatment Product and Solutions
    • 2.5.4 Teva Pharmaceuticals Eosinophilic Asthma Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Teva Pharmaceuticals Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Eosinophilic Asthma Treatment Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Eosinophilic Asthma Treatment by Company Revenue
    • 3.2.2 Top 3 Eosinophilic Asthma Treatment Players Market Share in 2023
    • 3.2.3 Top 6 Eosinophilic Asthma Treatment Players Market Share in 2023
  • 3.3 Eosinophilic Asthma Treatment Market: Overall Company Footprint Analysis
    • 3.3.1 Eosinophilic Asthma Treatment Market: Region Footprint
    • 3.3.2 Eosinophilic Asthma Treatment Market: Company Product Type Footprint
    • 3.3.3 Eosinophilic Asthma Treatment Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Eosinophilic Asthma Treatment Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Eosinophilic Asthma Treatment Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Eosinophilic Asthma Treatment Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Eosinophilic Asthma Treatment Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Eosinophilic Asthma Treatment Consumption Value by Type (2019-2030)
  • 6.2 North America Eosinophilic Asthma Treatment Market Size by Application (2019-2030)
  • 6.3 North America Eosinophilic Asthma Treatment Market Size by Country
    • 6.3.1 North America Eosinophilic Asthma Treatment Consumption Value by Country (2019-2030)
    • 6.3.2 United States Eosinophilic Asthma Treatment Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Eosinophilic Asthma Treatment Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Eosinophilic Asthma Treatment Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Eosinophilic Asthma Treatment Consumption Value by Type (2019-2030)
  • 7.2 Europe Eosinophilic Asthma Treatment Consumption Value by Application (2019-2030)
  • 7.3 Europe Eosinophilic Asthma Treatment Market Size by Country
    • 7.3.1 Europe Eosinophilic Asthma Treatment Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Eosinophilic Asthma Treatment Market Size and Forecast (2019-2030)
    • 7.3.3 France Eosinophilic Asthma Treatment Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Eosinophilic Asthma Treatment Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Eosinophilic Asthma Treatment Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Eosinophilic Asthma Treatment Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Eosinophilic Asthma Treatment Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Eosinophilic Asthma Treatment Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Eosinophilic Asthma Treatment Market Size by Region
    • 8.3.1 Asia-Pacific Eosinophilic Asthma Treatment Consumption Value by Region (2019-2030)
    • 8.3.2 China Eosinophilic Asthma Treatment Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Eosinophilic Asthma Treatment Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Eosinophilic Asthma Treatment Market Size and Forecast (2019-2030)
    • 8.3.5 India Eosinophilic Asthma Treatment Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Eosinophilic Asthma Treatment Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Eosinophilic Asthma Treatment Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Eosinophilic Asthma Treatment Consumption Value by Type (2019-2030)
  • 9.2 South America Eosinophilic Asthma Treatment Consumption Value by Application (2019-2030)
  • 9.3 South America Eosinophilic Asthma Treatment Market Size by Country
    • 9.3.1 South America Eosinophilic Asthma Treatment Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Eosinophilic Asthma Treatment Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Eosinophilic Asthma Treatment Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Eosinophilic Asthma Treatment Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Eosinophilic Asthma Treatment Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Eosinophilic Asthma Treatment Market Size by Country
    • 10.3.1 Middle East & Africa Eosinophilic Asthma Treatment Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Eosinophilic Asthma Treatment Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Eosinophilic Asthma Treatment Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Eosinophilic Asthma Treatment Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Eosinophilic Asthma Treatment Market Drivers
  • 11.2 Eosinophilic Asthma Treatment Market Restraints
  • 11.3 Eosinophilic Asthma Treatment Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Eosinophilic Asthma Treatment Industry Chain
  • 12.2 Eosinophilic Asthma Treatment Upstream Analysis
  • 12.3 Eosinophilic Asthma Treatment Midstream Analysis
  • 12.4 Eosinophilic Asthma Treatment Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Eosinophilic asthma (EA) is a type of severe asthma. It’s marked by high levels of white blood cells. This report mianly studies Eosinophilic Asthma Treatment market.
    According to our (Global Info Research) latest study, the global Eosinophilic Asthma Treatment market size was valued at US$ 19660 million in 2023 and is forecast to a readjusted size of USD 182110 million by 2030 with a CAGR of 37.9% during review period.
    Global key Eosinophilic Asthma treatment brands include Regeneron Pharmaceuticals & Sanofi, Genentech (Roche Group) & Novartis and GSK etc. The top 3 companies hold a share about 88%. North America is the largset market with a share about 40%, followed by Europe and Asia-Pacific.
    In terms of treatment, subcutaneous injection is the largest segment with a share of 95%. And in terms of end users, adult is the largest end user with a share about 55%.
    This report is a detailed and comprehensive analysis for global Eosinophilic Asthma Treatment market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global Eosinophilic Asthma Treatment market size and forecasts, in consumption value ($ Million), 2019-2030
    Global Eosinophilic Asthma Treatment market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
    Global Eosinophilic Asthma Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
    Global Eosinophilic Asthma Treatment market shares of main players, in revenue ($ Million), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Eosinophilic Asthma Treatment
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Eosinophilic Asthma Treatment market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AstraZeneca, GSK, Genentech (Roche Group) & Novartis, Regeneron Pharmaceuticals & Sanofi, Teva Pharmaceuticals, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Eosinophilic Asthma Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segmentation
    Eosinophilic Asthma Treatment market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Intravenous Infusion
    Subcutaneous Injection
    Market segment by Application
    Children
    Adults
    Teenagers
    Market segment by players, this report covers
    AstraZeneca
    GSK
    Genentech (Roche Group) & Novartis
    Regeneron Pharmaceuticals & Sanofi
    Teva Pharmaceuticals
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Eosinophilic Asthma Treatment product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Eosinophilic Asthma Treatment, with revenue, gross margin, and global market share of Eosinophilic Asthma Treatment from 2019 to 2024.
    Chapter 3, the Eosinophilic Asthma Treatment competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Eosinophilic Asthma Treatment market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Eosinophilic Asthma Treatment.
    Chapter 13, to describe Eosinophilic Asthma Treatment research findings and conclusion.

    Buy now